Hadasit Bio Fundamental Relationships

HDST -- Israel Stock  

ILS 478.60  3.20  0.66%

The Drivers Module shows relationships between Hadasit Bio's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Hadasit Bio Holdings Ltd over time as well as its relative position and ranking within its peers. Please also check Risk vs Return Analysis.

Hadasit Bio Holdings EBITDA vs. Price to Sales Fundamental Analysis

Hadasit Bio Holdings Ltd is one of the top stocks in price to sales category among related companies. It is rated # 4 in ebitda category among related companies .
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Hadasit Bio 
P/S 
 = 
MV Per Share 
Revenue Per Share 
=
221.94X
The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Hadasit Bio 
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
=
(23.98M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Hadasit Bio Holdings EBITDA Comparison

  EBITDA 
      Headstrong Comparables 
Hadasit Bio is currently under evaluation in ebitda category among related companies.
  Revenue 
      Headstrong Comparables 
Hadasit Bio is currently under evaluation in revenue category among related companies.
Search macroaxis.com